Pure Global AI
NCT06298487Recruiting

Evaluation of the Impact of Therapeutic Education Workshops for COPD Patients in the North-West Val d'Oise Area

Evaluation of the Multidimensional Impact of Therapeutic Education Workshops for COPD Patients, Cared for by the Maison de Prévention de la Santé et d'Accompagnement Thérapeutique, in the North-West Val d'Oise Area
Hôpital NOVOClinicalTrials.govother
Verified
Study focus
Disease/Condition
COPD
Drug/Device/Intervention
Patient questionnaires
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Hôpital NOVO
Location
Pontoise, France
Timeline & enrollment
Phase
N/A
Start date
Mar 11, 2024
End date
Sep 01, 2024
Enrollment
100 participants
Primary outcome

Evaluation of the overall impact of the PTE workshops offered by the MPSAT on patients' knowledge, skills, attitudes and behaviours with regard to COPD management and care

Summary

The aim of this study is to assess the impact of the Patient Therapeutic Education (PTE)
 workshops offered by the Maison de Prévention de la Santé et d'Accompagnement Thérapeutique
 (MPSAT) on the follow-up and feelings of the COPD patients who take part. These workshops are
 organised outside the hospital environment and supervised by hospital and town professionals
 in the NOVO zone.

ICD-10 classifications
Chronic obstructive pulmonary disease, unspecifiedOther chronic obstructive pulmonary diseaseOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedPulmonary heart disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06298487
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06298487 through Pure Global AI's free database. This phase not specified trial is sponsored by Hôpital NOVO and is currently Recruiting. The study focuses on COPD. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.